Editing
AUA: Stone Surgery (2016)
(section)
Jump to navigation
Jump to search
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
== Treatment of Renal Stones == === UrologySchool.com summary === * '''<span style="color:#ff0000">Asymptomatic, non-obstructing caliceal stones: active surveillance</span>''' * '''<span style="color:#ff0000">Symptomatic, total stone burden < 20mm</span>''' ** '''<span style="color:#ff0000">Non-lower pole: either SWL or URS</span>''' are preferred over PCNL ** '''<span style="color:#ff0000">Lower pole:</span>''' *** '''<span style="color:#ff0000">β€10mm: SWL or URS</span>''' *** '''<span style="color:#ff0000">10-20mm: PCNL (first-line) or URS (no SWL)</span>''' * '''<span style="color:#ff0000">Symptomatic, total stone burden >20mm: PCNL (first-line) or URS (option) (no SWL)</span>''' [[File:2019auastonesxpathway.jpg|alt=2019 AUA Guideline Algorithm of Selecting Surgical Treatment of Stones|center|thumb|734x734px|2019 AUA Guideline Algorithm of Selecting Surgical Treatment of Stones]] === Asymptomatic, non-obstructing caliceal stones === * '''Active surveillance may be offered''' ** Observation of asymptomatic, non-obstructing caliceal stones is appropriate as long as the patient is counseled about the risk of stone growth, passage, and pain. ** '''There is conflicting data on the natural history of asymptomatic renal stones''' *** '''β50% of asymptomatic stones will progress, a much smaller percentage will require surgical intervention.''' **** Lower pole stone location and isolated stone β₯ 4 mm were associated with a higher likelihood of failing observation. ** '''Treatment of asymptomatic, non-obstructing caliceal stones should be considered in:''' **# '''Cases of associated infection''' **# '''Vocational reasons (e.g. airline pilots, military)''' **# '''Poor access to medical care''' ** If observation is chosen for asymptomatic, non-obstructing caliceal stones, '''follow-up imaging studies to assess for stone growth or new stone formation is recommended'''. Dietary modifications and medical therapy may be considered, especially if new stone formation occurs === Symptomatic === * '''Total stone burden β€20mm''' ** '''Non-lower pole stone''' *** '''Recommended options: SWL or URS''' **** '''Treatment options for patients with a <20 mm non-lower pole renal stone burden include SWL, URS, and PCNL'''. Of these, PCNL stone-free rates are the least affected by stone size, while stone-free rates of both SWL and URS decline with increasing stone burden. However, '''for stone burdens <20mm, stone-free rates of both URS and SWL are acceptable and have less morbidity compared to PCNL'''. ** '''Lower pole stone''' *** '''β€ 10 mm''' **** '''Recommended options: SWL or URS''' ***** An RCT found that there was no significant difference between the stone-free rates with URS vs. SWL. Intraoperative complications were higher with URS, and patient-derived QoL measures were better with SWL in this trial. ***** '''CT imaging parameters should be used for patient selection.''' *** '''> 10mm''' **** '''Recommended options: PCNL (preferred) or URS; SWL not recommended''' ***** '''Clinicians should inform patients with lower pole stones >10 mm in size that PCNL has a higher stone-free rate but greater morbidity [than URS].''' ***** '''PCNL should be considered the primary treatment''' * '''Stone burden > 20 mm''' ** '''Recommended options: PCNL (first-line) or URS (option); SWL not recommended as first-line''' *** Significantly reduced stone-free rates and increased need for multiple treatments for SWL compared to PCNL for patients with a total renal stone burden > 20 mm **** Success of SWL is dependent on several other factors, including obesity, skin-to-stone distance, collecting system anatomy, stone composition and stone density/attenuation, which could also contribute to lower stone-free rates **** The benefit of a higher stone-free rate must be weighed against the increased invasiveness and risk of complications for PCNL compared to URS or SWL. ***** 15% overall complication rate with PNCL, majority categorized as Clavien Grade I. '''Bleeding necessitating blood transfusion (7%) is the most common complication''' **** The risk of ureteral obstruction from stone fragments (steinstrasse) increases * '''Staghorn calculi''' ** '''PCNL is the first-line treatment''' === Open/ laparoscopic /robotic surgery === * '''Should not be offered as first-line therapy to most patients with stones.''' ** '''Exceptions include:''' *** '''Rare cases of anatomic abnormalities with large or complex stones''' *** '''Requiring concomitant reconstruction, such as those with''' '''concomitant UPJ obstruction or ureteral stricture.''' === Nephrectomy === * '''In patients requiring treatment, nephrectomy may be performed when the involved kidney has negligible function''' * '''Observation may be appropriate for some asymptomatic patients. However, poorly functioning kidneys can often be a source of persistent infection, pain, and pyelonephritis. In these cases, nephrectomy may be the best treatment option to relieve symptoms and prevent systemic complications, such as sepsis and xanthogranulomatous pyelonephritis.''' * When considering nephrectomy for the poorly functioning kidney, overall renal function and the condition of the kidney on the contralateral side should be considered. * '''Nephrectomy should be avoided, if possible, in pregnant patients until after they deliver.'''
Summary:
Please note that all contributions to UrologySchool.com may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
UrologySchool.com:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
Navigation menu
Personal tools
Not logged in
Talk
Contributions
Create account
Log in
Namespaces
Page
Discussion
English
Views
Read
Edit
Edit source
View history
More
Search
Navigation
Main page
Clinical Tools
Guidelines
Chapters
Landmark Studies
Videos
Contribute
For Patients & Families
MediaWiki
Recent changes
Random page
Help about MediaWiki
Tools
What links here
Related changes
Special pages
Page information